RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Betamethasone

Allergic States, Dermatologic Diseases, Endocrine Disorders, Gastrointestinal Diseases, Hematologic Disorders, Neoplastic Diseases

Indications

  • Allergic States
  • Dermatologic Diseases
  • Endocrine Disorders
  • Gastrointestinal Diseases
  • Hematologic Disorders
  • Neoplastic Diseases

Adult dosing

  • initial systemic: dose: 0.25; unit: mg; route: IM; interval: 0.25 to 9.0 mg per day; fixed: true; labelExcerpt: The initial dosage of parenterally administered CELESTONE ® SOLUSPAN ® Injectable Suspension may vary from 0.25 to 9.0 mg per day depending on the specific disease entity being treated.
  • multiple sclerosis: dose: 30; unit: mg; route: IM; interval: 30 mg daily for 1 week, then 12 mg every other day for 1 month; fixed: true; labelExcerpt: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 30 mg of betamethasone for a week followed by 12 mg every other day for 1 month are recommended
  • bursitis tenosynovitis: dose: 1; unit: mL; route: intrabursal - CELESTONE SOLUSPAN injectable suspension: betamethasone 3 mg/mL (as sodium phosphate) + betamethasone acetate 3 mg/mL; interval: one injection; fixed: true; labelExcerpt: In acute subdeltoid, subacromial, olecranon, and prepatellar bursitis, one intrabursal injection of 1.0 mL CELESTONE SOLUSPAN Injectable Suspension can relieve pain and restore full range of movement.
  • intra articular: dose: 0.5; unit: mL; route: intra-articular - CELESTONE SOLUSPAN injectable suspension: betamethasone 3 mg/mL (as sodium phosphate) + betamethasone acetate 3 mg/mL; interval: 0.5 to 2.0 mL; fixed: true; labelExcerpt: Following intra-articular administration of 0.5 to 2.0 mL of CELESTONE SOLUSPAN Injectable Suspension, relief of pain, soreness, and stiffness may be experienced.
  • antenatal fetal lung maturity: Consult pharmacy/current label

Pediatric dosing

  • initial: dose: 0.02; unit: mg/kg/day; route: IM; interval: 0.02 to 0.3 mg/kg/day in three or four divided doses; weightBased: false; pedNote: No label-stated per-dose maximum verified; weight-based calculation disabled. Consult pharmacy/current label.; labelExcerpt: The range of initial doses is 0.02 to 0.3 mg/kg/day in three or four divided doses (0.6 to 9 mg/m 2 bsa/day).

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Consult pharmacy/current label

Contraindications

  • Hypersensitivity
  • Idiopathic thrombocytopenic purpura (IM use)

Clinical pearls

  • DO NOT administer intravenously.
  • Monitor growth velocity in pediatric patients.
  • Monitor for signs of infection, as corticosteroids can suppress the immune system and mask signs of infection.
  • Withdraw gradually after long-term therapy.

Source and review

  • DailyMed label (betamethasone acetate and betamethasone sodium phosphate, CELESTONE SOLUSPAN), Set ID 95a19c2f-c329-4ce1-a0a7-174814aac3ad, effective 2026-04-24; ACOG Committee Opinion No. 713 (2017, PMID 28742678) - paywalled; abstract has no dose; not verified. Last reviewed: 2026-11-11